Abstract
In Phase 3 clinical trials (SINUS-24/-52; NCT02912468/NCT02898454), dupilumab treatment improved sense of smell in patients with chronic rhinosinusitis with nasal polyps (CRSwNP). We report a post hoc analysis of olfactory outcomes in patients from SINUS-52.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
